John Wiley & Sons Inc. (WLY)
43.52
-0.11 (-0.25%)
At close: Apr 25, 2025, 3:59 PM
43.57
0.13%
After-hours: Apr 25, 2025, 05:29 PM EDT
John Wiley & Sons Revenue Breakdown
| Period Ending | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 |
|---|---|---|---|---|---|---|
| Research Segment Revenue | 261.88M | 265.31M | 13.23M | 256.2M | 257.67M | 515.61M |
| Research Segment Revenue Growth | -1.29% | +1905.66% | -94.84% | -0.57% | -50.03% | n/a |
Revenue by Geography
| Period Ending | Apr 30, 2024 | Apr 30, 2023 | Apr 30, 2022 |
|---|---|---|---|
| Canada Revenue | 76.51M | 83.04M | 140.32M |
| Canada Revenue Growth | -7.86% | -40.82% | n/a |
| China Revenue | 120.21M | 150.94M | 94.04M |
| China Revenue Growth | -20.36% | +60.51% | n/a |
| Japan Revenue | 84.85M | 89.08M | 353.92M |
| Japan Revenue Growth | -4.76% | -74.83% | n/a |
| Other Countries Revenue | 544.17M | 332.88M | n/a |
| Other Countries Revenue Growth | +63.47% | n/a | n/a |
| United States Revenue | 881.79M | 995.92M | n/a |
| United States Revenue Growth | -11.46% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Dec 6, 2017 | Oct 31, 2017 | Aug 31, 2017 | Apr 30, 2017 | Dec 9, 2016 | Oct 31, 2016 | Aug 29, 2016 | Apr 30, 2016 | Feb 29, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | 248.82M | 252.06M | 253.38M | 252.28M | 255.8M | 245.82M | 255.8M | 253.03M | 282.75M | 279.33M | 275.48M | 264.19M | 260.59M | 286.88M | 251.24M | 247.17M | 237.37M | 261.12M | 245.68M | 240.38M | 250.17M | 246.23M | 240.72M | 248.63M | 253.77M | 262.68M | 248.75M | 239.32M | 243.81M | 258.82M | 247.28M | 247.27M | 235.65M | 261.49M | 250.66M | 239.99M | 242.5M | 249.46M | 250.48M |
| Selling, General, and Administrative Revenue Growth | -100.00% | -1.29% | -0.52% | +0.43% | -1.38% | +4.06% | -3.90% | +1.09% | -10.51% | +1.22% | +1.40% | +4.27% | +1.38% | -9.17% | +14.19% | +1.65% | +4.13% | -9.10% | +6.28% | +2.21% | -3.91% | +1.60% | +2.29% | -3.18% | -2.03% | -3.39% | +5.60% | +3.94% | -1.84% | -5.80% | +4.67% | 0.00% | +4.93% | -9.88% | +4.32% | +4.45% | -1.04% | -2.79% | -0.41% | n/a |
| Research and Development Revenue | n/a | n/a | 4.94M | 4.96M | 6.25M | 6.69M | 7.19M | n/a | 8.16M | 8.29M | 8.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | -100.00% | -0.32% | -20.69% | -6.54% | -7.01% | n/a | -100.00% | -1.50% | -2.49% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |